
Viltaz 4.5 Injection
Marketer
Viilbery Healthcare Pvt Ltd
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Viltaz 4.5 Injection
Combiflox 4.5 Injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered exclusively by medical professionals, the dosage and frequency are determined by your physician based on illness severity. Strict adherence to prescribed usage is vital. Potential side effects encompass nausea, vomiting, diarrhea, and skin rashes, along with localized injection site reactions such as pain, swelling, or erythema. Persistent or worsening side effects necessitate immediate medical consultation. Prior to treatment, disclose any antibiotic allergies or pre-existing kidney or liver conditions; dosage adjustments or alternative medications may be necessary. Under medical guidance, this injection is generally considered safe for use during pregnancy and lactation.
Uses of Viltaz 4.5 Injection
Infections caused by bacteria
Major Benefits of Viltaz 4.5 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Viltaz 4.5 Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Viltaz 4.5 Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Viltaz 4.5 Injection works:
Viltaz 4.5 Injection unites Piperacillin, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. The addition of Tazobactum counteracts bacterial resistance mechanisms, thereby boosting Piperacillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Viltaz 4.5 Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Viltaz 4.5 is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; yet, clinical data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable formulation of Viltaz 4.5 is considered safe for use while breastfeeding. Research in humans indicates negligible transfer of the medication into breast milk, posing no known risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Viltaz 4.5 Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
The use of Viltaz 4.5 Injection requires careful consideration in individuals with impaired kidney function. A modified dosage of Viltaz 4.5 Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Viltaz 4.5 Injection in individuals with hepatic impairment appears to pose minimal risk. Existing evidence indicates that dosage modification may be unnecessary. However, physician consultation is recommended.
What if you forget to take Viltaz 4.5 Injection :
Omitting a scheduled dose of Viltaz 4.5 Injection warrants immediate physician consultation.
Facts to Know About Viltaz 4.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
